% costs of drug design

@article{paul2010improve,
  title={How to improve R\&D productivity: the pharmaceutical industry's grand challenge},
  author={Paul, Steven M and Mytelka, Daniel S and Dunwiddie, Christopher T and Persinger, Charles C and Munos, Bernard H and Lindborg, Stacy R and Schacht, Aaron L},
  journal={Nature reviews Drug discovery},
  volume={9},
  number={3},
  pages={203--214},
  year={2010},
  publisher={Nature Publishing Group}
}

@article{dimasi2003price,
  title={The price of innovation: new estimates of drug development costs},
  author={DiMasi, Joseph A and Hansen, Ronald W and Grabowski, Henry G},
  journal={Journal of health economics},
  volume={22},
  number={2},
  pages={151--185},
  year={2003},
  publisher={Elsevier}
}

@article{adams2010spending,
  title={Spending on new drug development1},
  author={Adams, Christopher Paul and Brantner, Van Vu},
  journal={Health economics},
  volume={19},
  number={2},
  pages={130--141},
  year={2010},
  publisher={Wiley Online Library}
}

@article{dimasi2001risks,
  title={Risks in new drug development: approval success rates for investigational drugs},
  author={DiMasi, Joseph A},
  journal={Clinical Pharmacology And Therapeutics St Louis},
  volume={69},
  number={5},
  pages={297--307},
  year={2001},
  publisher={Mosby-Year Book Inc}
}

@article{adams2006estimating,
  title={Estimating the cost of new drug development: is it really \$802 million?},
  author={Adams, Christopher P and Brantner, Van V},
  journal={Health Affairs},
  volume={25},
  number={2},
  pages={420--428},
  year={2006},
  publisher={Health Affairs}
}

@article{dimasi2010trends,
  title={Trends in risks associated with new drug development: success rates for investigational drugs},
  author={DiMasi, Joseph A and Feldman, L and Seckler, A and Wilson, A},
  journal={Clinical Pharmacology \& Therapeutics},
  volume={87},
  number={3},
  pages={272--277},
  year={2010},
  publisher={Nature Publishing Group}
}

@article{gandhi2006extensively,
  title={Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa},
  author={Gandhi, Neel R and Moll, Anthony and Sturm, A Willem and Pawinski, Robert and Govender, Thiloshini and Lalloo, Umesh and Zeller, Kimberly and Andrews, Jason and Friedland, Gerald},
  journal={The Lancet},
  volume={368},
  number={9547},
  pages={1575--1580},
  year={2006},
  publisher={Elsevier}
}

@article{duch2007artificial,
  title={Artificial intelligence approaches for rational drug design and discovery},
  author={Duch, Wlodzislaw and Swaminathan, Karthikeyan and Meller, Jaroslaw},
  journal={Current pharmaceutical design},
  volume={13},
  number={14},
  pages={1497--1508},
  year={2007},
  publisher={Bentham Science Publishers}
}

@article{klopman1984artificial,
  title={Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules},
  author={Klopman, Gilles},
  journal={Journal of the American Chemical Society},
  volume={106},
  number={24},
  pages={7315--7321},
  year={1984},
  publisher={ACS Publications}
}

@article{scannell2012diagnosing,
  title={Diagnosing the decline in pharmaceutical R\&D efficiency},
  author={Scannell, Jack W and Blanckley, Alex and Boldon, Helen and Warrington, Brian},
  journal={Nature reviews Drug discovery},
  volume={11},
  number={3},
  pages={191--200},
  year={2012},
  publisher={Nature Publishing Group}
}
